Which is better, MDGL or VKTX?

On the Buffett-Fit framework, Madrigal Pharmaceuticals, Inc. (MDGL) currently grades higher than VKTX — 26/100 (F grade) vs 18/100 (F). That said, "better" depends on which framework you trust — MDGL wins on Warren Buffett, Benjamin Graham, Joel Greenblatt, and Charlie Munger; VKTX wins on Philip Fisher, Peter Lynch, and Terry Smith. The full pillar breakdown is on this page.

Should I buy MDGL or VKTX?

This page is an educational comparison, not investment advice. Both MDGL and VKTX are graded against the same Buffett 5-pillar framework (moat, earnings durability, management quality, financial health, valuation) plus six other documented investor frameworks. Read the side-by-side breakdown to see which one matches the criteria you care about most — and always do your own research before making any investment decision.

Is MDGL better than VKTX for value investing?

On the Buffett-style value-investing framework, MDGL currently grades higher — 26/100 vs 18/100, a 8-point gap. The gap is driven by which pillars each stock passes; the table on this page shows moat, durability, management, financial health, and valuation side-by-side.

What's the difference between MDGL and VKTX on Warren Buffett's framework?

Both stocks are evaluated on the same five pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety). MDGL currently scores 26/100 (F grade); VKTX scores 18/100 (F grade). The "Where each wins" section on this page breaks down which pillar each stock dominates.

Which has the stronger moat, MDGL or VKTX?

Moat strength is one of the five pillars in the Buffett-Fit score on this page. MDGL and VKTX are each scored on ROIC sustainability, gross-margin durability, and qualitative signals like brand strength, switching costs, network effects, and regulatory barriers. The pillar breakdown on this page shows the moat sub-score side-by-side so you can see which one has the more durable competitive advantage.

Which is more undervalued, MDGL or VKTX?

Valuation is one of the five Buffett-Fit pillars on this page. Both stocks are scored on owner-earnings yield, price-to-intrinsic-value vs the underlying compounding rate, and the margin of safety relative to a conservative DCF. The valuation sub-score in the table below tells you which one currently trades at a more attractive price relative to its underlying business quality.

Are MDGL and VKTX both Healthcare stocks?

Yes — both Madrigal Pharmaceuticals, Inc. (MDGL) and Viking Therapeutics, Inc. (VKTX) operate in the Healthcare sector. That makes this a direct sector-peer comparison, which is the apples-to-apples way to use the Buffett-Fit framework: the score weighs each stock against its sector's specific quality and valuation benchmarks (sector-relative bonus), so the cross-stock comparison isn't distorted by inter-sector base-rate differences.

Is this MDGL vs VKTX comparison investment advice?

No. This page is an educational pattern-match against documented public frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith), not personalised investment advice. The scores reflect how closely each stock matches each framework's documented criteria — they are not buy/hold/sell recommendations. Always do your own research and consult a licensed financial adviser for personalised advice.

Stock comparison

Madrigal Pharmaceuticals

Viking Therapeutics

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

MDGL

Market cap

$12.07B

Sector

Healthcare

VKTX

Viking Therapeutics

Market cap

$3.33B

Sector

Healthcare

Overall winner

Madrigal Pharmaceuticals MDGL

Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.

Fit scores by strategy

Strategy	MDGL	VKTX	Winner
Warren Buffett	26F	18F	MDGL
Benjamin Graham	60D	53D	MDGL
Philip Fisher

Side-by-side metrics

Metric	MDGL	VKTX
Market cap	$12.07B	$3.33B
P/E (TTM)	-	-
EV/EBIT	-	-
ROIC (TTM)	-35.2%	-100.02%
Gross margin	93.07%	0.0%
Net margin	-27.32%	0.0%
Revenue CAGR 5y	-

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

MDGL leads on

Gross margin93.07%vs 0.0%+100%
P/E (TTM)-vs -+86%
EV/EBIT-vs -+80%
Market cap$12.07Bvs $3.33B

More like MDGL

MDGL vs IDXX MDGL vs LMAT MDGL vs MTD MDGL vs HALO MDGL vs HRMY MDGL vs RPRX

More like VKTX

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.